在墨西哥晚期发病的亨廷顿病:一项回顾性研究
Adriana Ochoa-Morales1, Kerstin Beutelspacher-Fernandez1, Aurelio Jara-Prado1
1Genetics Department, National Institute of Neurology and Neurosurgery Manuel Velasco Suárez, Mexico City, MEX.
Cureus
|November 14, 2025
概括
晚期发病的亨廷顿病 (LoHD) 是罕见的,通常缺乏家族病史,并表现出运动症状. 需要进一步的研究,以了解这些亨廷顿病患者中延迟发病的因素.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 神经学 神经学
背景情况:
- 亨廷顿病 (HD) 是一种主要的神经退行性疾病,通常在成年期开始.
- 晚发性亨廷顿病 (LoHD) 是一种不太常见的形式,在60岁后开始.
- 了解LoHD特征对于诊断和管理至关重要.
研究的目的:
- 描述墨西哥一家领先的神经中心LoHD患者的主要特征.
- 分析LoHD的人口,临床和分子方面.
- 为了确定影响亨廷顿病延迟发病的潜在因素.
主要方法:
- 从1994年到2024年中期,对HD患者病历进行了回顾性,横截面的研究.
- 数据收集包括年龄,发病,诊断延迟,家族病史,分子结果和临床表现.
- 针对运动功能的统一亨廷顿病评级尺度-总动力得分 (UHDRS-TMS) 的分析.
主要成果:
- 在1476名HD患者中,有104人 (7%) 患有LoHD,其中56.7%为女性.
- 发病平均年龄为65.1岁,平均诊断延迟时间为6.2岁.
- 平均CAG重复次数为41.4,89%的人出现了初始运动症状.
结论:
- LoHD是一种罕见的亨廷顿病变体,表现不同.
- 很大一部分LoHD病例没有家族病史.
- 在LoHD中,CAG重复的长度与典型的HD重叠,需要对发病修饰物的研究.
相关概念视频
Long-term Depression
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...


